Atrial Fibrillation: Causes, Investigations, and Treatment
Published: 2021-12-20
Page: 377-387
Issue: 2021 - Volume 4 [Issue 1]
Omar Elsaka *
Department of Cardiology, Mansoura University, Faculty of Medicine, Mansoura Manchester Medical Program (MMMP), Mansoura, Egypt.
*Author to whom correspondence should be addressed.
Abstract
Background: Atrial fibrillation (AF) is a frequent progressive cardiac arrhythmia that worsens with age and the presence of comorbidities in the heart. A rapid and irregular heartbeat, known as atrial fibrillation, can go unnoticed or cause symptoms such as palpitations, shortness of breath, and dizziness. This disorder has been linked to more catastrophic consequences, such as an increased risk of stroke. Recent advances in the clinical epidemiology and management of AF have taught us something new about how we should approach the disease. This guidebook covers the epidemiology, techniques, and pathophysiology of AF, as well as diagnosis, testing, prevention, and therapy. Stroke prevention, quality control, and rhythm control are among the management options evaluated. We also discuss health-care quality and offer predictions for future developments and clinical trials to treat this prevalent cardiac arrhythmia.
Conclusion: AF was linked to a two-fold increase in the likelihood of VTE episodes. When those with PE other than DVT were excluded, the link was less, suggesting that the increased risk of VTE in patients with AF could be due to AF-related abnormalities or risk factors.
Keywords: Atrial fibrillation, sinus rhythm, atrial enlargement, paroxysmal atrial fibrillation, accessory pathway